NCT00469326View on ClinicalTrials.gov

Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Coronary Artery Disease
Interventions
DRUG

Atorvastatin

two days 80mg atorvastatin pre-treatment before PCI

Trial Locations (1)

150 18

Department of Cardiology, CardioVascular Center, University Hospital Motol, Prague

All Listed Sponsors
lead

University Hospital, Motol

OTHER

NCT00469326 - Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study | Biotech Hunter | Biotech Hunter